Showing results (221-230 of 5,917) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|November 10, 2020
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosisElena Raschi, Daniela Privitera, Caterina Bodio, et al.
Arthritis Research & Therapy|November 10, 2020
Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cellsMinoru Shigesaka, Tomoki Ito, Muneo Inaba, et al.
Arthritis Research & Therapy|November 10, 2020
Gene expression identifies patients who develop inflammatory arthritis in a clinically suspect arthralgia cohortEllis Niemantsverdriet, Erik B van den Akker, Debbie M Boeters, et al.
Arthritis Research & Therapy|September 5, 2020
Association between knee alignment, osteoarthritis disease severity, and subchondral trabecular bone microarchitecture in patients with knee osteoarthritis: a cross-sectional studyXuequan Han, Junqi Cui, Kai Xie, et al.
Arthritis Research & Therapy|September 20, 2020
AST/ALT ratio as a predictor of mortality and exacerbations of PM/DM-ILD in 1 year-a retrospective cohort study with 522 casesRenjiao Li, Wen-Jun Zhu, Faping Wang, et al.
Arthritis Research & Therapy|September 10, 2020
Secukinumab leads to shifts from stage-based towards response-based disease clusters-comparative data from very early and established psoriatic arthritisEleni Kampylafka, Koray Tascilar, Veronika Lerchen, et al.
Arthritis Research & Therapy|September 16, 2020
Patients' and rheumatologists' perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritisLaurette van Boheemen, Janne W Bolt, Marieke M Ter Wee, et al.
Arthritis Research & Therapy|September 26, 2020
Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherenceBenoit Blanchet, Moez Jallouli, Marie Allard, et al.
Arthritis Research & Therapy|September 30, 2020
Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous groupIrini Genitsaridi, Irini Flouri, Dimitris Plexousakis, et al.
Arthritis Research & Therapy|September 11, 2020
The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based studyImke Redeker, Johanna Callhoff, Falk Hoffmann, et al.
Pageof 592